Volume 130, Issue 11

Search all Journal of Neural Transmission articles

November 2023

Special Issue: Therapy of Advanced Parkinson´s Disease: Long Neglected, Now in Focus

Issue Editor:

Wolfgang H. Jost

16 articles in this issue

If you can't be with the one you love, love the one you're with (C, S, N & Y)
Wolfgang H. Jost
Editorial 13 January 2023 Pages: 1321 - 1322
L-DOPA-therapy in Parkinson’s disease: some personal reflections on L-DOPA therapy from Vienna and Berlin
Peter Riederer
Reinhard Horowski
Neurology and Preclinical Neurological Studies - Review Article Open access 05 October 2023 Pages: 1323 - 1335
Adopting the Rumsfeld approach to understanding the action of levodopa and apomorphine in Parkinson’s disease
P. Jenner
C. Falup-Pecurariu
W. H. Jost
Neurology and Preclinical Neurological Studies - Review Article Open access 20 May 2023 Pages: 1337 - 1347
Current and novel infusion therapies for patients with Parkinson's disease
Angelo Antonini
Valentina D’Onofrio
Andrea Guerra
Neurology and Preclinical Neurological Studies - Review Article Open access 06 September 2023 Pages: 1349 - 1358
Tools and criteria to select patients with advanced Parkinson’s disease for device-aided therapies: a narrative review
Harmen R. Moes
Tove Henriksen
Teus van Laar
Neurology and Preclinical Neurological Studies - Review Article Open access 27 July 2023 Pages: 1359 - 1377
Apprends-moi l'art des petits pas: Levodopa, Carbidopa Intestinal Gel plus Entacapone
Wolfgang H. Jost
Neurology and Preclinical Neurological Studies - Original Article Open access 28 April 2023 Pages: 1379 - 1382
Optimised endoscopic access for intrajejunal levodopa application in idiopathic Parkinson's syndrome
K. E. Grund
A. Zipfel
W. H. Jost
Neurology and Preclinical Neurological Studies - Original Article Open access 21 February 2023 Pages: 1383 - 1394
Should continuous dopaminergic stimulation be a standard of care in advanced Parkinson’s disease?
Z. Pirtošek
V. Leta
M. Vérin
Neurology and Preclinical Neurological Studies - Review Article 06 November 2023 Pages: 1395 - 1404
Are Parkinson’s disease patients referred too late for device-aided therapies and how can better informed and earlier referrals be encouraged?
Fran Borovečki
Romana Perković
Regina Katzenschlager
Neurology and Preclinical Neurological Studies - Original Article 01 August 2023 Pages: 1405 - 1409
Access to device-aided therapies in advanced Parkinson’s disease: navigating clinician biases, patient preference, and prognostic uncertainty
Manon Auffret
Daniel Weiss
Wolfgang H. Jost
Neurology and Preclinical Neurological Studies - Review Article Open access 12 July 2023 Pages: 1411 - 1432
Towards improved access to device-aided therapies in advanced PD: the importance of cooperation of different disciplines
Jaime Kulisevsky
Cristian Falup-Pecurariu
Wolfgang H. Jost
Neurology and Preclinical Neurological Studies - Review Article 13 July 2023 Pages: 1433 - 1441
Non-oral continuous drug delivery based therapies and sleep dysfunction in Parkinson’s disease
P. Tall
M. A. Qamar
K. Ray Chaudhuri
Neurology and Preclinical Neurological Studies - Review Article Open access 01 May 2023 Pages: 1443 - 1449
Homocysteine, vitamin B metabolites, dopamine-substituting compounds, and symptomatology in Parkinson’s disease: clinical and therapeutic considerations
Onanong Phokaewvarangkul
Roongroj Bhidayasiri
Thomas Müller
Neurology and Preclinical Neurological Studies - Review Article 21 August 2023 Pages: 1451 - 1462
Feasibility and benefits of home initiation of subcutaneous apomorphine infusion for patients with Parkinson’s disease: the APOKADO study
Fabien Zagnoli
Amélie Leblanc
The APOKADO Group
Neurology and Preclinical Neurological Studies - Original Article Open access 02 March 2023 Pages: 1463 - 1474
Practical use of apomorphine infusion in Parkinson’s disease: lessons from the TOLEDO study and clinical experience
Tove Henriksen
Regina Katzenschlager
Andrew Lees
Neurology and Preclinical Neurological Studies - Original Article Open access 01 September 2023 Pages: 1475 - 1484
Home initiation of apomorphine infusion: lessons from the COVID-19 pandemic and implications for current clinical practice
Christopher Kobylecki
Lucy Partington-Smith
Neurology and Preclinical Neurological Studies - Original Article Open access 23 October 2023 Pages: 1485 - 1489

Volume 130, Issue 11

If you can't be with the one you love, love the one you're with (C, S, N & Y)

L-DOPA-therapy in Parkinson’s disease: some personal reflections on L-DOPA therapy from Vienna and Berlin

Adopting the Rumsfeld approach to understanding the action of levodopa and apomorphine in Parkinson’s disease

Current and novel infusion therapies for patients with Parkinson's disease

Tools and criteria to select patients with advanced Parkinson’s disease for device-aided therapies: a narrative review

Apprends-moi l'art des petits pas: Levodopa, Carbidopa Intestinal Gel plus Entacapone

Optimised endoscopic access for intrajejunal levodopa application in idiopathic Parkinson's syndrome

Should continuous dopaminergic stimulation be a standard of care in advanced Parkinson’s disease?

Are Parkinson’s disease patients referred too late for device-aided therapies and how can better informed and earlier referrals be encouraged?

Access to device-aided therapies in advanced Parkinson’s disease: navigating clinician biases, patient preference, and prognostic uncertainty

Towards improved access to device-aided therapies in advanced PD: the importance of cooperation of different disciplines

Non-oral continuous drug delivery based therapies and sleep dysfunction in Parkinson’s disease

Homocysteine, vitamin B metabolites, dopamine-substituting compounds, and symptomatology in Parkinson’s disease: clinical and therapeutic considerations

Feasibility and benefits of home initiation of subcutaneous apomorphine infusion for patients with Parkinson’s disease: the APOKADO study

Practical use of apomorphine infusion in Parkinson’s disease: lessons from the TOLEDO study and clinical experience

Home initiation of apomorphine infusion: lessons from the COVID-19 pandemic and implications for current clinical practice

Navigation